These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 34269798

  • 1. Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study.
    Gill H, Yung Y, Chu HT, Au WY, Yip PK, Lee E, Yim R, Lee P, Cheuk D, Ha SY, Leung RYY, Ma ESK, Kumana CR, Kwong YL.
    Blood Adv; 2021 Jul 27; 5(14):2829-2838. PubMed ID: 34269798
    [Abstract] [Full Text] [Related]

  • 2. Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.
    Wen J, Xu F, Zhou Q, Shi L, Liu Y, Yue J, Zhang Y, Liang X.
    BMC Cancer; 2023 Jan 07; 23(1):27. PubMed ID: 36611025
    [Abstract] [Full Text] [Related]

  • 3. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Jan 07; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 4. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
    Zhu HH, Wu DP, Du X, Zhang X, Liu L, Ma J, Shao ZH, Ren HY, Hu JD, Xu KL, Wang JW, Song YP, Fang MY, Li J, Yan XY, Huang XJ.
    Lancet Oncol; 2018 Jul 07; 19(7):871-879. PubMed ID: 29884593
    [Abstract] [Full Text] [Related]

  • 5. Long-term survey of outcome in acute promyelocytic leukemia.
    Hu J, Shen Z, Sun H, Wu W, Li X, Sun G, Wang Z.
    Chin Med J (Engl); 2000 Feb 07; 113(2):107-10. PubMed ID: 11775530
    [Abstract] [Full Text] [Related]

  • 6. Oral arsenic trioxide, all-trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long-term results and unique prognostic indicators.
    Gill HS, Yim R, Kumana CR, Tse E, Kwong YL.
    Cancer; 2020 Jul 15; 126(14):3244-3254. PubMed ID: 32365228
    [Abstract] [Full Text] [Related]

  • 7. [Therapies for newly diagnosed acute promyelocytic leukemia].
    Yokoyama Y.
    Rinsho Ketsueki; 2020 Jul 15; 61(9):1166-1173. PubMed ID: 33162512
    [Abstract] [Full Text] [Related]

  • 8. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy.
    Abla O, Ribeiro RC, Testi AM, Montesinos P, Creutzig U, Sung L, Di Giuseppe G, Stephens D, Feusner JH, Powell BL, Hasle H, Kaspers GJL, Dalla-Pozza L, Lassaletta A, Tallman MS, Locatelli F, Reinhardt D, Lo-Coco F, Hitzler J, Sanz MA.
    Ann Hematol; 2017 Sep 15; 96(9):1449-1456. PubMed ID: 28597167
    [Abstract] [Full Text] [Related]

  • 9. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
    Adès L, Thomas X, Bresler AG, Raffoux E, Spertini O, Vey N, Marchand T, Récher C, Pigneux A, Girault S, Deconinck E, Gardin C, Tournilhac O, Lambert JF, Chevallier P, de Botton S, Lejeune J, Dombret H, Chevret S, Fenaux P.
    Haematologica; 2018 Dec 15; 103(12):2033-2039. PubMed ID: 30026341
    [Abstract] [Full Text] [Related]

  • 10. The characteristics and long-term outcomes of acute promyelocytic leukemia patients with early intracranial hemorrhage.
    Li H, Niu T, Huang J, Xie L, He C, Li J, Xiang B, Cui X, Wu Y, Tang Y, Jia Y, Liu Z, Ma H.
    Int J Hematol; 2023 Apr 15; 117(4):538-543. PubMed ID: 36522588
    [Abstract] [Full Text] [Related]

  • 11. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
    Zhang L, Zou Y, Chen Y, Guo Y, Yang W, Chen X, Wang S, Liu X, Ruan M, Zhang J, Liu T, Liu F, Qi B, An W, Ren Y, Chang L, Zhu X.
    BMC Cancer; 2018 Apr 03; 18(1):374. PubMed ID: 29615003
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of early switching to an outpatient therapy model using oral arsenic plus retinoic acid based-regimen in newly diagnosed acute promyelocytic leukemia.
    Lou Y, Tong H, Yu W, Wei J, Xu W, Mao L, Jin J.
    Leuk Res; 2019 Aug 03; 83():106168. PubMed ID: 31202077
    [Abstract] [Full Text] [Related]

  • 13. [Acute promyelocytic leukemia: state-of-the-art management].
    Asou N.
    Rinsho Ketsueki; 2018 Aug 03; 59(6):725-734. PubMed ID: 29973452
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide.
    Jin B, Zhang Y, Hou W, Cao F, Lu M, Yang H, Tian X, Wang Y, Hou J, Fu J, Li H, Zhou J.
    J Cancer Res Clin Oncol; 2020 Feb 03; 146(2):485-492. PubMed ID: 31686248
    [Abstract] [Full Text] [Related]

  • 15. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.
    Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo D, Petti MC, Mandelli F.
    Blood; 1996 Aug 15; 88(4):1390-8. PubMed ID: 8695858
    [Abstract] [Full Text] [Related]

  • 16. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
    Zhang X, Zhang H, Chen L, Wang M, Xi J, Liu X, Xie M, Li D, Gulati ES, Gong S, Wang H.
    Trials; 2018 Sep 05; 19(1):476. PubMed ID: 30185214
    [Abstract] [Full Text] [Related]

  • 17. Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.
    Gill H, Kumana CR, Yim R, Hwang YY, Chan TSY, Yip SF, Lee HKK, Mak V, Lau JSM, Chan CC, Kho B, Wong RSM, Li W, Lin SY, Lau CK, Ip HW, Leung RYY, Lam CCK, Kwong YL.
    Cancer; 2019 Sep 01; 125(17):3001-3012. PubMed ID: 31090936
    [Abstract] [Full Text] [Related]

  • 18. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
    Zhao S, Ge Y, Li Z, Yang T.
    Front Immunol; 2023 Sep 01; 14():1100151. PubMed ID: 37063881
    [Abstract] [Full Text] [Related]

  • 19. Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical study.
    Yang MH, Wan WQ, Luo JS, Zheng MC, Huang K, Yang LH, Mai HR, Li J, Chen HQ, Sun XF, Liu RY, Chen GH, Feng X, Ke ZY, Li B, Tang YL, Huang LB, Luo XQ.
    Am J Hematol; 2018 Dec 01; 93(12):1467-1473. PubMed ID: 30160789
    [Abstract] [Full Text] [Related]

  • 20. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK, Russell NH, Hills RK, Bowen D, Kell J, Knapper S, Morgan YG, Lok J, Grech A, Jones G, Khwaja A, Friis L, McMullin MF, Hunter A, Clark RE, Grimwade D, UK National Cancer Research Institute Acute Myeloid Leukaemia Working Group.
    Lancet Oncol; 2015 Oct 01; 16(13):1295-305. PubMed ID: 26384238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.